The increase in potential exposure in recent years is apparent from our study, in which, among a broader cohort of more than 2.1 million pregnancies, the prevalence of GLP-1 dispensing in the 90 days prior to the last menstrual period and conception increased from 2 per 1,000 in 2020 to 15 per 1,000 in 2024, Brown explained
Rates vary depending on the specific drug and dose, but studies show that around 10% of people taking semaglutide report headachesmost commonly during the first few weeks or after a dose increase
Illegal use of Melanotan I and II has been reported and regulatory authorities have issued warnings in the United States and Europe.1,2 Melatonin I and II are synthetic melanocortin analogs ( melanocyte-stimulating hormone) with greater potency and a longer half-life than endogenous melanocyte-stimulating hormone
Its crucial to follow the prescribed dosage to ensure safety and effectiveness
however, immunotherapy at this time is not standard of care